Advertisement

Related Videos

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Amit Sanyal, MD: A Clinician’s Perspective

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Mar
13
Today In Oncology
Female Reproductive Cancers Linked to Reduced Survival Advantage Over Males
p53 Reactivator Rezatapopt in TP53 Y220C–Mutated Solid Tumors
BCMA CAR T-Cell Therapy in Newly Diagnosed Multiple Myeloma
Disease Stage at Breast Cancer Diagnosis Impacted by Region Race and Insurance
Can Viral Respiratory Infections Increase Lung Cancer Risk
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo